当前位置: 首页 >> 检索结果
共有 3390 条符合本次的查询结果, 用时 3.0169494 秒

81. The Influence of Disease Prevalence on Diagnostic Performance of Lung Ultrasound in Rheumatoid Arthritis-Associated Interstitial Lung Disease.

作者: Horacio Matías Castro.
来源: Chest. 2025年168卷4期e133-e134页

82. Response.

作者: Angel O Coz Yataco.
来源: Chest. 2025年168卷4期e132-e133页

83. Risks Make Routine Plasma and Platelet Transfusion Recommendations Concerning in Certain Critical Care Populations.

作者: Brian D Adkins.;Sean G Yates.;Ravi Sarode.
来源: Chest. 2025年168卷4期e131-e132页

84. Response.

作者: Kevin P Seitz.;Matthew W Semler.;Jonathan D Casey.
来源: Chest. 2025年168卷4期e130-e131页

85. Volume Control Is Not Always Volume Control.

作者: Uddalak Majumdar.;Robert L Chatburn.;Eduardo Mireles-Cabodevila.
来源: Chest. 2025年168卷4期e129-e130页

86. Response.

作者: Cuiqiong Dai.;Fan Wu.;Yumin Zhou.;Pixin Ran.
来源: Chest. 2025年168卷4期e128-e129页

87. Methodologic Considerations in Preserved Ratio Impaired Spirometry and Airflow Limitation Assessment.

作者: Nadia Ben Lazreg.;Mariem Abdesslem.;Helmi Ben Saad.
来源: Chest. 2025年168卷4期e127-e128页

88. Response.

作者: Hira A Awan.;Alejandro P Comellas.;Eric A Hoffman.;Joseph M Reinhardt.
来源: Chest. 2025年168卷4期e125-e126页

89. Radiomic Signatures in COPD: The Need to Integrate Eosinophilic and Autoimmune Endotypes.

作者: Ajeetha Priya Gajendiran.;Mayuri Mudgal.;Kulothungan Gunasekaran.
来源: Chest. 2025年168卷4期e125页

90. Response.

作者: Chao Liu.;Hui Xiong.;Shuyun Xu.;Liangkai Chen.
来源: Chest. 2025年168卷4期e123-e125页

91. Frailty and COPD: Emphasizing Dynamic Phenotyping and Additive Interaction for Precision Risk Assessment.

作者: Yang Liu.;Qian Li.;Ying Liu.;Ke Xu.
来源: Chest. 2025年168卷4期e122-e123页

92. Extending the Lens: Long-Term Impact of COVID-19 on COPD Management and Outcomes.

作者: Sang Hyuk Kim.;Ji-Yong Moon.;Min Gu Kang.;Jong Seung Kim.;Kyung Hoon Min.;Hyun Lee.
来源: Chest. 2025年168卷4期e121-e122页

93. Newly Onset Dyspnea During Pregnancy.

作者: Marie Vermant.;Valerie Van Ballaer.;Tine Follet.;Eveline Claeys.;Samuel De Bontridder.;Nico De Crem.;Adriana Dubbeldam.;Alexandros Kalkanis.;Laurens J De Sadeleer.;Ellen De Langhe.;Wim A Wuyts.
来源: Chest. 2025年168卷4期e115-e120页

94. Respiratory Dyskinesia With Refractory Tachypnea and Alkalosis Treated by Vesicular Monoamine Transporter 2 Inhibitor.

作者: Yue-Jing Wu.;Qian He.;Fu-Gang Luo.;Tao Li.;Wan-Jun Guo.
来源: Chest. 2025年168卷4期e111-e113页
We present the case of a 69-year-old woman with a 25-year history of psychosis, managed with risperidone, who developed refractory tachypnea and alkalosis over 2 weeks. Despite multidisciplinary evaluation, she was initially misdiagnosed with psychogenic hyperventilation. Ultimately, a diagnosis of respiratory dyskinesia (RD) was established, and substantial clinical improvement was achieved after initiation of a vesicular monoamine transporter 2 (VMAT2) inhibitor. The substantial effectiveness of this therapy was confirmed over a 7-month follow-up period, with monitoring of both clinical symptoms and arterial blood gas parameters. This case highlights the diagnostic challenges posed by RD and underscores the potential utility of VMAT2 inhibitor as a novel therapeutic option.

95. A 44-Year-Old Man With a Solitary, Slowly Enlarging Mediastinal Lesion.

作者: Vasiliki Kolokotroni.;Garyfallia Perlepe.;Angeliki Cheva.;Christoforos Foroulis.;Konstantinos I Gourgoulianis.
来源: Chest. 2025年168卷4期e107-e110页
A 44-year-old man, who does not smoke, presented for investigation of a right mediastinum lesion as revealed on a routine radiograph that was performed as a requirement of his life insurance. The patient reported no associated symptoms. He did not report shortness of breath, cough, sputum, fever, chest pain, or hemoptysis. The remaining review of symptoms was also negative for issues such as muscle weakness, weight loss, night sweats, fatigue, skin rash, and visible, palpable, or painful lymphadenopathy. His medical history was unremarkable, and he did not receive any regular medication. The patient's professional occupation was not related to special exposure and he did not report alcohol consumption, illicit drug use, or any recent travel.

96. Music in Practice.

作者: Daniel Song.
来源: Chest. 2025年168卷4期994-995页

97. Estimating Heterogeneous Treatment Effects With Target Trial Emulation: A Checklist of Causal Machine Learning for Observational Data.

作者: Xiaofeng Wang.;Yan Zou.;Yifan Wang.;Chao Zhang.
来源: Chest. 2025年168卷4期856-859页

98. Measuring What Matters: The Pseudo-Productivity Paradox in Health Care.

作者: Scott M Matson.
来源: Chest. 2025年168卷4期853-855页

99. Sleeping With the Enemy: The Hidden Burden of OSA Among Military Personnel.

作者: Peter A Cistulli.;Atul Malhotra.;Jean-Louis Pepin.
来源: Chest. 2025年168卷4期850-852页

100. Smells Like Preterm Bronchopulmonary Dysplasia: A Novel Path Forward for Predicting Prematurity-Associated Bronchopulmonary Dysplasia.

作者: Telford Yeung.;Bonny Jasani.
来源: Chest. 2025年168卷4期848-849页
共有 3390 条符合本次的查询结果, 用时 3.0169494 秒